K Schluns
Overview
Explore the profile of K Schluns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hufnagl P, Lohmann S, Schluns K, Zerbe N
Pathologe
. 2018 Apr;
39(3):222-227.
PMID: 29704046
Background: The "Digital Pathology in Diagnostics - Assessment of Digital Images" guideline describes the technical and legal framework under which the use of this digital technology is justifiable for the...
2.
Hufnagl P, Schluns K
Pathologe
. 2008 Oct;
29 Suppl 2:250-4.
PMID: 18841365
There are several areas of application for virtual microscopy in pathology. After broad use in education and research, we are now seeing its initial application in health care. We can...
3.
Chen Y, Pacyna-Gengelbach M, Ye F, Knosel T, Lund P, Deutschmann N, et al.
J Pathol
. 2007 Jan;
211(4):431-8.
PMID: 17236181
The expression of insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is decreased in various tumours, but the role of IGFBP-rP1 in lung cancer is not yet clear. In this...
4.
Knosel T, Schluns K, Stein U, Schwabe H, Schlag P, Dietel M, et al.
Histopathology
. 2003 Sep;
43(4):323-31.
PMID: 14511250
Aims: To investigate the prognostic significance of chromosomal alterations in colorectal cancer patients. Histopathological tumour classification is still considered to be the gold standard for the characterization of solid tumours....
5.
Difilippantonio S, Chen Y, Pietas A, Schluns K, Pacyna-Gengelbach M, Deutschmann N, et al.
Eur J Cancer
. 2003 Aug;
39(13):1936-47.
PMID: 12932674
Suppression subtractive hybridisation (SSH) was performed comparing normal bronchial epithelial cells with a lung squamous cell carcinoma (SCC) and a metastatic small-cell lung carcinoma (SCLC). The sequence analysis of four...
6.
Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I
Br J Cancer
. 2003 Mar;
88(2):231-6.
PMID: 12610508
Originally identified as a B-cell marker, expression of the cell surface molecule CD24 has meanwhile been observed in a variety of human malignancies. It appears to function as a ligand...
7.
Kristiansen G, Yu Y, Petersen S, Kaufmann O, Schluns K, Dietel M, et al.
Eur J Cancer
. 2001 May;
37(9):1089-95.
PMID: 11378338
Overexpression of the c-erbB2 protein is observed in a variety of malignancies including non-small cell lung cancer (NSCLC). We aimed to determine the rate of c-erbB2-overexpression in our tumour collection...
8.
Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I
Am J Pathol
. 2000 Aug;
157(2):369-75.
PMID: 10934141
Chromosomal imbalances in 113 primary head and neck squamous cell carcinomas (HNSCCs) determined by comparative genomic hybridization were correlated with patients survival using custom-made computer software which enabled the assessment...
9.
Petersen I, Hidalgo A, Petersen S, Schluns K, Schewe C, Pacyna-Gengelbach M, et al.
Brain Pathol
. 2000 Jul;
10(3):395-401.
PMID: 10885658
Metastases account for approximately 50% of the malignant tumors in the brain. In order to identify structural alterations that are associated with tumor dissemination into the central nervous system we...
10.
Richard F, Pacyna-Gengelbach M, Schluns K, Fleige B, Winzer K, Szymas J, et al.
Int J Cancer
. 2000 Jun;
89(3):305-10.
PMID: 10861509
Invasive breast carcinomas are characterized by a complex pattern of chromosomal alterations. We applied comparative genomic hybridization (CGH) to analyze 105 primary breast carcinomas using histograms to indicate the incidence...